These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12293563)
21. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data]. Gaspard U; Dubois M Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen. Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148 [TBL] [Abstract][Full Text] [Related]
24. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments]. Le Coutour X NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304 [TBL] [Abstract][Full Text] [Related]
25. Trends in oral contraceptive development and utilization: looking to the future. Contracept Rep; 1997 Jan; 7(5):4-13. PubMed ID: 12320650 [TBL] [Abstract][Full Text] [Related]
26. Examine use of low- and lower-dose OCs. Contracept Technol Update; 2000 Jun; 21(6):72-3. PubMed ID: 12295925 [TBL] [Abstract][Full Text] [Related]
27. Progestagen-releasing vaginal rings--an update. Nuttal ID; Elstein M; Spencer BE IPPF Med Bull; 1985 Apr; 19(2):1-2. PubMed ID: 12266929 [TBL] [Abstract][Full Text] [Related]
28. [Contraceptive development for the future]. Zatuchni GI Contracept Fertil Sex (Paris); 1984 Jun; 12(6):769-79. PubMed ID: 12313176 [TBL] [Abstract][Full Text] [Related]
29. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen. Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292 [TBL] [Abstract][Full Text] [Related]
30. [Metrorrhagia caused by estrogen-progestin combinations]. Erny R; Erny N Contracept Fertil Sex (Paris); 1994 Feb; 22(2):93-7. PubMed ID: 12319056 [TBL] [Abstract][Full Text] [Related]
31. Vaginal epithelial surface appearances in women using vaginal rings for contraception. Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Lähteenmäki P; Elomaa K; Weisberg E; Nash HA Contraception; 2000 Feb; 61(2):131-8. PubMed ID: 10802278 [TBL] [Abstract][Full Text] [Related]
32. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage. Verhoeven CH; Dieben TO Contraception; 2004 Mar; 69(3):197-9. PubMed ID: 14969666 [TBL] [Abstract][Full Text] [Related]
33. Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study). Pelissier C; Basdevant A; Conard J; Egloff M; Husson T; Guyenne TT Contracept Fertil Sex (Paris); 1987 Jan; 15(1):45-54. PubMed ID: 12315161 [TBL] [Abstract][Full Text] [Related]
34. [Study of endometrial maturation under the influence of an oestrogen-progestin combination containing 30 mcg of EE and 150 mcg of desogestrel: the value of biopsy of the endometrium in assessing the efficacy of an oestrogen-progestin combination]. Nahmanovici C; De Brux J; Audebert A; Berdah J; Mayer M; Bouchard P Fertil Contracept Sex; 1988 Apr; 16(4):305-8. PubMed ID: 12342377 [TBL] [Abstract][Full Text] [Related]